Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
Genmab to Webcast Post ASH Investor Seminar Wall Street Journal The following cancer experts and senior Genmab staff will attend the event: -- Professor Peter Hillmen, Professor of Experimental Haematology, University of Leeds and Honorary... 
No comment yet.
Sign up to comment
Scoop.it!
From
trialx
Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy (#clinicaltrials Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy: BT-062, an ant...)...
|
Scoop.it!
CAMBRIDGE, Mass. July 31, 2012 - Mersana Therapeutics, Inc., a biopharmaceutical company developing its Fleximer® antibody-drug conjugate platform and (Mersana Therapeutics, Inc.
|
